Trekrezan: founder of a new class of adaptogens and immunomodulators
M. G. Voronkov, M. M. Rasulov · 2007 · Khimiko-Farmatsevticheskii Zhurnal 41(1):3–7
What does this source report?
A chemistry and development anchor covering immune, stress and tissue-repair research branches.
- Population and setting
- Historical pharmacology review
- Evidence type
- Review
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian; English abstract where indicated
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Broad therapeutic proposals in a review are not established indications or independently appraised clinical findings.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Citation and available abstract or selected source passages checked; complete methods and risk-of-bias appraisal pending.
Recorded source-check date: 2026-09-30. This date does not imply a completed systematic review.
Cite and trace this record
Original source: M. G. Voronkov, M. M. Rasulov. Trekrezan: founder of a new class of adaptogens and immunomodulators Khimiko-Farmatsevticheskii Zhurnal 41(1):3–7 2007.
Molekul research summary: https://molekul.io/research/trek-voronkov-2007. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry